Home arrow Transplants & Organ Donations arrow European Group For Blood And Marrow Transplantation Annual Congress
Advertisement

Main Menu

Home
Advertisement
Advertisement

Most popular articles


Study Finds Transplant Patient Thrives 2 Years After Stopping Immunosuppressive Drugs
Saturday, 26 January 2008
Luck smiled on Larry Kowalski when his brother agreed to donate a kidney Kowalski required to live. He was even luckier that his brother's kidney was such a wonderful match.

Kidney Transplant Chain Initiated At NewYork-Presbyterian/Weill Cornell
Thursday, 21 February 2008
On Valentine's Day, one of the nation's first three-way living-donor kidney transplant chains was initiated by NewYork-Presbyterian Hospital/Weill Cornell Medical Center and its medical partner The Rogosin Institute.

Australian Medical Association Urges Organ Donors To Make Their Wishes Known
Monday, 18 February 2008
During Australian Organ Donor Awareness Week, the AMA is urging Australians who wish to be organ donors to make their intent clear by registering as a donor and talking to their family about their wishes.

Body Art Delivers Hard-Hitting Message About Shortage Of Donated Organs, UK
Friday, 08 February 2008
The lack of donated organs for transplants is to be highlighted in a national press advertising campaign featuring eye-catching body art. The images feature a male and female model with a picture of a heart painted on their bodies under the message: 'You've got what it takes to save a life'.

Surgeons Use Transplant Surgery To Remove Tumour
Tuesday, 25 March 2008
In a 15-hour operation, surgeons in the US used transplant surgery to remove and modify multiple abdominal organs so they could reach and cut out a tumour in a female patient who had a infrequent form of cancer.

Putting The Beat Back Into Weak Hearts
Friday, 15 February 2008
A new device could put the beat back into weak hearts - and free patients from a lifetime of anti-rejection drugs. Current implanted heart assist devices function by sucking blood from the ventricles and then expelling it into downstream vessels.

Immunosuppressant Further Linked To Birth Defects
Thursday, 07 February 2008
A new study documents malformations seen in an infant born to a kidney transplant recipient who had taken mycophenolate mofetil (MMF), a broadly used immunosuppressant available commercially as Cellcept®.
Advertisement
European Group For Blood And Marrow Transplantation Annual Congress Print E-mail
User Rating: / 0
PoorBest 
Health and Medical News - Transplants & Organ Donations
Friday, 07 March 2008



EBMT, the European Group for Blood and Marrow Transplantation, will host over 4,000 top scientists, physicians, nurses, caregivers, patients and their families, and others during its 5-day Annual Congress in Florence, Italy. This meeting is a forum for the scientific exchange between physicians, nurses, and data managers, as well as a place for families, patients and others to meet, network, and exchange their experiences. The Annual Congress is planned to enhance the crucial close interaction with the leaders of each discipline in a harmonious programme.

The 34th EBMT Annual Congress

This year's Annual Congress is predicted to be an even larger success than last year's meeting in Lyon where EBMT welcomed over 3,600 delegates from more than 75 countries. This year's Annual Congress in Florence from 30th March to 2nd April will also be the 24th Meeting of the EBMT Nurses Group, the 7th Meeting of the EBMT Data Management Group, and the 2nd Patient and Family Day.

The Congress has been carefully prepared to offer a scientifically productive and very informative meeting with plenary sessions, educational sessions, workshops, lunch sessions and joint sessions covering all-important topics and presented by the top experts in the field. This year the 2 plenary sessions focus on speedily changing issues: the evolution of Graft-versus-Host-Disease (GvHD) and a session on Cord Blood Transplantation. The combination of this scientific meeting with the nurses', data managers' and statisticians' programmes highlights the multidisciplinary character of the EBMT Annual Congress.

The 2nd EBMT Patient & Family Day

The 2nd EBMT Patient & Family Day will take place in Florence on Saturday 29th March 2008. The EBMT Board decided to repeat this initiative based on the success of the first event in Lyon last year, in line with the Group's goal of improving communication between EBMT professionals and patients. The programme will incorporate the suggestions and experience gained from the first exchanges with patients and families. It has been designed to explore both scientific trends and the special relationship which frequently exists between the clinical BMT personnel and patients and their families.

This info day will consist of 2 presentations, four plenary sessions and six workshops led by physicians, nurses, patients, donors and family members. The 2 presentations will be "Overview of transplant activity in Europe" and "Clinical evolution of GvHD".

For more info on the Congress and to see the full schedule, please visit http://www.akm.ch/ebmt2008.

About the European Group for Blood and Marrow Transplantation

Bone marrow or stem cell transplantation is frequently the only curative treatment for different malignant diseases and is presently performed on more that 50,000 patients worldwide each year. The European Group for Blood and Marrow Transplantation (EBMT) as the leading non-profit, scientific society representing 530 transplant centres in and outside Europe, promotes all activity aiming to advance stem cell transplantation or cellular therapy. This includes registering all the activity relating to stem cell transplants with a view to improving treatment outcomes for patients. EBMT has set standards for indication and treatment for malignant and non-malignant diseases, along with running training programmes for continual professional development. These are continually audited and updated. EBMT is also responsible for accrediting the transplant centres based on their performance and data reporting.

European Group for Blood and Marrow Transplantation



 
Latest news in this category:

Use of stem cells for neural transplantation
Wednesday, 13 August 2008
Neutral transplantation has been used to study and promote the regenerative potential of the brain after an ischemic insult.

Non-surgical Hair Restoration
Monday, 30 June 2008
Though surgical hair restoration is a viable option, it may not be suitable for everybody, because of different medical reasons. Along with such candidates, there are people who do not prefer the option of surgery, or those who may wish their surgical restoration to look even better.

Researchers Attempting To Mimic The Way A Parasite Manipulates The Immune System
Saturday, 12 April 2008
One day it may be possible to mimic the tactics used by parasites to trick the body into accepting transplanted tissues or organs.

Organ Transplant Waiting List Reaches High In U.S.
Friday, 11 April 2008
Donate Life America and the United Network for Organ Sharing (UNOS) are using the month of April to educate Americans about the number of lives that could be saved and advanced through organ, eye and tissue transplants.

Research Presented At ISHLT Shows Promise Of Addressing Critical Organ Shortage
Friday, 11 April 2008
Data from experimental work on the use of organs from cardiac arrested donors is being presented this week at the International Society for Heart and Lung Transplantation's 28th Annual Meeting and Scientific Sessions.

US Hospital Performs First Six-Way Kidney Swap Transplant
Wednesday, 09 April 2008
Surgeons at the The Johns Hopkins Hospital in Baltimore, Maryland, USA, have carried out the first simultaneous six-way kidney transplant operation involving six donors and six recipients that were paired using a "domino" system that relies on altruistic donation to facilitate better matching of...

Government Announces Appointment Of New National Clinical Director For Transplant, UK
Friday, 04 April 2008
The Department of Health announced the appointment of a new 'transplant tsar' to drive forward Government plans to increase the number of people who can benefit from an organ transplant.